Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China · Delayed Price · Currency is CNY 12.03
-0.13 (-1.07%)
Nov 13, 2026, 3:00 PM CST
SHA:600557 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,039 | 2,148 | 2,195 | 1,979 | 1,601 | 937.44 |
Trading Asset Securities | - | - | 40 | 460 | 170 | 176 |
Cash & Short-Term Investments | 2,039 | 2,148 | 2,235 | 2,439 | 1,771 | 1,113 |
Cash Growth | -5.48% | -3.89% | -8.36% | 37.70% | 59.08% | 43.98% |
Accounts Receivable | 569.99 | 599.59 | 700.54 | 1,092 | 1,471 | 1,350 |
Other Receivables | 13.62 | 11.57 | 6.33 | 5.48 | 9.67 | 11.75 |
Receivables | 583.61 | 611.16 | 706.87 | 1,098 | 1,480 | 1,362 |
Inventory | 375.1 | 452.56 | 540.27 | 350.11 | 342.82 | 338.08 |
Other Current Assets | 90.46 | 101.28 | 113.69 | 188.65 | 135.32 | 60.91 |
Total Current Assets | 3,088 | 3,313 | 3,596 | 4,076 | 3,730 | 2,874 |
Property, Plant & Equipment | 3,225 | 2,899 | 2,752 | 2,539 | 2,508 | 2,533 |
Long-Term Investments | 4.15 | 11.1 | 15.34 | 15.32 | 45.61 | 60.64 |
Goodwill | 58.99 | 58.99 | 58.99 | 58.99 | 58.99 | 58.99 |
Other Intangible Assets | 382.32 | 239.07 | 171.46 | 198.17 | 231.15 | 282.73 |
Long-Term Deferred Tax Assets | 47.43 | 45.13 | 45.31 | 46.22 | 15.96 | 16.77 |
Long-Term Deferred Charges | 93.9 | 215.54 | 203.84 | 192.67 | 184.79 | 171.14 |
Other Long-Term Assets | 49.94 | 80.67 | 64.4 | 62.81 | 21.63 | 20.72 |
Total Assets | 6,950 | 6,863 | 6,907 | 7,189 | 6,796 | 6,018 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 280.36 | 226.39 | 226.87 | 236.61 | 373.36 | 359.75 |
Accrued Expenses | 88.07 | 712.4 | 880.74 | 1,030 | 814.57 | 531.14 |
Short-Term Debt | - | 406.3 | 486.08 | 422.74 | - | 234.5 |
Current Portion of Leases | - | 0.25 | - | - | - | - |
Current Income Taxes Payable | - | 2.03 | 2.14 | 2.42 | 2.1 | 2.05 |
Current Unearned Revenue | 21.21 | 27.74 | 25.46 | 25.17 | 214.87 | 25.34 |
Other Current Liabilities | 1,238 | 346.07 | 423.19 | 325.68 | 376.2 | 300.08 |
Total Current Liabilities | 1,628 | 1,721 | 2,044 | 2,042 | 1,781 | 1,453 |
Long-Term Debt | - | - | 1.93 | 1.93 | 1.93 | 1.93 |
Long-Term Leases | 0.54 | 0.81 | - | - | - | - |
Long-Term Unearned Revenue | 142.63 | 128.22 | 155.27 | 126.16 | 78.78 | 90.52 |
Total Liabilities | 1,771 | 1,850 | 2,202 | 2,171 | 1,862 | 1,545 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 566.16 | 566.16 | 581.8 | 584.75 | 584.6 | 592.88 |
Additional Paid-In Capital | - | - | - | 178.29 | 98.13 | 171.79 |
Retained Earnings | 4,464 | 4,252 | 4,145 | 4,225 | 4,136 | 3,720 |
Treasury Stock | -45.09 | - | -211.98 | -48.14 | -64.7 | -180 |
Total Common Equity | 4,985 | 4,819 | 4,515 | 4,940 | 4,754 | 4,304 |
Minority Interest | 194.41 | 193.89 | 190.51 | 78.47 | 179.8 | 168.35 |
Shareholders' Equity | 5,179 | 5,012 | 4,705 | 5,019 | 4,934 | 4,473 |
Total Liabilities & Equity | 6,950 | 6,863 | 6,907 | 7,189 | 6,796 | 6,018 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.54 | 407.36 | 488.01 | 424.66 | 1.93 | 236.43 |
Net Cash (Debt) | 2,039 | 1,741 | 1,747 | 2,014 | 1,769 | 877.01 |
Net Cash Growth | -5.38% | -0.36% | -13.27% | 13.84% | 101.75% | 209.48% |
Net Cash Per Share | 3.62 | 3.09 | 3.03 | 3.47 | 3.05 | 1.53 |
Filing Date Shares Outstanding | 580.73 | 566.16 | 569.46 | 583.9 | 594.68 | 576.43 |
Total Common Shares Outstanding | 580.73 | 566.16 | 569.46 | 583.9 | 594.68 | 576.43 |
Working Capital | 1,461 | 1,592 | 1,551 | 2,033 | 1,949 | 1,421 |
Book Value Per Share | 8.58 | 8.51 | 7.93 | 8.46 | 7.99 | 7.47 |
Tangible Book Value | 4,543 | 4,520 | 4,284 | 4,683 | 4,464 | 3,963 |
Tangible Book Value Per Share | 7.82 | 7.98 | 7.52 | 8.02 | 7.51 | 6.87 |
Buildings | - | 2,650 | 2,483 | 2,402 | 2,460 | 2,398 |
Machinery | - | 1,509 | 1,340 | 1,318 | 1,233 | 1,191 |
Construction In Progress | - | 438.98 | 472.81 | 227.25 | 98.54 | 82.9 |